[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100650379":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":28,"locations":37,"responsibleParty":171,"collaborators":10,"id":173,"slug":174,"hasResults":175,"nctId":176,"briefTitle":177,"officialTitle":178,"acronym":179,"eligibilityCriteria":180,"healthyVolunteers":175,"sex":181,"minAge":182,"maxAge":10,"enrollmentInfo":183,"targetDuration":186,"studyType":187,"phases":10,"briefSummary":188,"conditions":189,"keywords":191,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":198,"lastUpdatePostDateStruct":199,"startDateStruct":202,"completionDateStruct":204,"leadSponsor":206,"locationsCount":207},{"fullName":5,"class":6},"Phenox GmbH","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Subjects with intracranial aneurysms (anterior and posterior) treated with p64, p48 MW and p64 MW",null,"The registry will include subjects across France who are treated for an intracranial aneurysm with a p64, p64 MW or p48 MW Flow Modulation Device.\n\nIn total, it is anticipated to include approximatively 200 subjects over the inclusion period: 160 subjects treated with p64 \u002Fp64 MW (80 %) and 40 subjects treated with p48 MW (20 %).",[13],"Device: Aneurysm treatment with a Flow Modulation Device",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","Aneurysm treatment with a Flow Modulation Device","Treatment of an intracranial aneurysm (anterior and posterior circulation) with a p64, p48 MW, or p64 MW Flow Modulation Device.",[9],[21,25],{"name":22,"affiliation":23,"role":24},"Laurent Pierot, Prof.","CHU de Reims","PRINCIPAL_INVESTIGATOR",{"name":26,"affiliation":27,"role":24},"Laurent Spelle, Prof.","Hôpital Bicêtre",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":10,"email":33},"Elisabeth Demant-Bauchspiess","CONTACT","+49 (0) 173 3099117","ceflow@wallabyphenox.com",{"name":35,"role":31,"phone":36,"phoneExt":10,"email":33},"Meike Arnold","+49 (0) 234 36 919 2530",[38,54,66,78,90,100,112,124,135,147,159],{"facility":39,"status":40,"city":41,"state":10,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"CHU Amiens-Picardie","RECRUITING","Amiens","80054","France","FR",{"type":46,"coordinates":47},"Point",[48,49],2.3,49.9,{"lat":49,"lon":48},[52],{"name":53,"role":31,"phone":10,"phoneExt":10,"email":10},"Cyril Chivot, Dr.",{"facility":55,"status":40,"city":56,"state":10,"zip":57,"country":43,"countryCode":44,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"CHU Bordeaux","Bordeaux","33076",{"type":46,"coordinates":59},[60,61],-0.58046,44.84124,{"lat":61,"lon":60},[64],{"name":65,"role":31,"phone":10,"phoneExt":10,"email":10},"Xavier Barreau, Dr.",{"facility":67,"status":40,"city":68,"state":10,"zip":69,"country":43,"countryCode":44,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"CHU Pierre Wertheimer","Bron","69500",{"type":46,"coordinates":71},[72,73],4.91303,45.73865,{"lat":73,"lon":72},[76],{"name":77,"role":31,"phone":10,"phoneExt":10,"email":10},"Roberto Riva, Dr.",{"facility":79,"status":40,"city":80,"state":10,"zip":81,"country":43,"countryCode":44,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"CHU Clermont-Ferrand","Clermont-Ferrand","63003",{"type":46,"coordinates":83},[84,85],3.08682,45.77969,{"lat":85,"lon":84},[88],{"name":89,"role":31,"phone":10,"phoneExt":10,"email":10},"Emmanuel Chabert, Prof.",{"facility":27,"status":40,"city":91,"state":10,"zip":92,"country":43,"countryCode":44,"cosmosGeoPoint":93,"geoPoint":97,"contacts":98},"Le Kremlin-Bicêtre","94270",{"type":46,"coordinates":94},[95,96],2.36073,48.81471,{"lat":96,"lon":95},[99],{"name":26,"role":31,"phone":10,"phoneExt":10,"email":10},{"facility":101,"status":40,"city":102,"state":10,"zip":103,"country":43,"countryCode":44,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"CHU de Limoges","Limoges","87042",{"type":46,"coordinates":105},[106,107],1.24759,45.83362,{"lat":107,"lon":106},[110],{"name":111,"role":31,"phone":10,"phoneExt":10,"email":10},"Charbel Mounayer, Prof.",{"facility":113,"status":40,"city":114,"state":10,"zip":115,"country":43,"countryCode":44,"cosmosGeoPoint":116,"geoPoint":120,"contacts":121},"Hôpital Pitié-Salpêtrière","Paris","75651",{"type":46,"coordinates":117},[118,119],2.3488,48.85341,{"lat":119,"lon":118},[122],{"name":123,"role":31,"phone":10,"phoneExt":10,"email":10},"Frédéric Clarençon, Prof.",{"facility":125,"status":40,"city":126,"state":10,"zip":127,"country":43,"countryCode":44,"cosmosGeoPoint":128,"geoPoint":132,"contacts":133},"CHU Reims","Reims","51092",{"type":46,"coordinates":129},[130,131],4.02853,49.26526,{"lat":131,"lon":130},[134],{"name":22,"role":31,"phone":10,"phoneExt":10,"email":10},{"facility":136,"status":40,"city":137,"state":10,"zip":138,"country":43,"countryCode":44,"cosmosGeoPoint":139,"geoPoint":143,"contacts":144},"CHU Rouen","Rouen","76031",{"type":46,"coordinates":140},[141,142],1.09932,49.44313,{"lat":142,"lon":141},[145],{"name":146,"role":31,"phone":10,"phoneExt":10,"email":10},"Nicolas Fonne, Dr.",{"facility":148,"status":40,"city":149,"state":10,"zip":150,"country":43,"countryCode":44,"cosmosGeoPoint":151,"geoPoint":155,"contacts":156},"CHRU Strasbourg","Strasbourg","67091",{"type":46,"coordinates":152},[153,154],7.74553,48.58392,{"lat":154,"lon":153},[157],{"name":158,"role":31,"phone":10,"phoneExt":10,"email":10},"Raoul Pop, Dr.",{"facility":160,"status":40,"city":161,"state":10,"zip":162,"country":43,"countryCode":44,"cosmosGeoPoint":163,"geoPoint":167,"contacts":168},"CHU Tours","Tours","37044",{"type":46,"coordinates":164},[165,166],0.70398,47.39484,{"lat":166,"lon":165},[169],{"name":170,"role":31,"phone":10,"phoneExt":10,"email":10},"Denis Herbreteau, Prof.",{"type":172,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100650379","pmcf-registry-to-describe-the-safety-and-performance-of-p64-p48-mw-and-p64-mw-in-france-100650379",false,"NCT07748572","PMCF Registry to Describe the Safety and Performance of p64, p48 MW and p64 MW in France","CEFloW (Clinical Experience With Flow Diverter With and Without Movable Wire)","CEFloW","Inclusion Criteria:\n\n* 1\\. Age ≥ 18 years and legally of age.\n* 2\\. The patient has intracranial aneurysm(s) \\* and is treated or planned to be treated with p64, p48 MW or p64 MW Devices. (\\*cases of ruptured aneurysms in the context of a staged procedure or not treatable by another technique, and cases of multiple aneurysms are eligible)\n* 3\\. The patient or his\u002Fher legal representative (in case the patient does not have the capacity due to his\u002Fher clinical condition), does not object to the collection and processing of the data specified in the protocol.\n\nExclusion Criteria:\n\n* 1\\. Participation in an interventional study modifying standard patient care management (e.g. COATING study)\n* 2\\. State or circumstance that does not allow the patient to undergo the standard site's follow-up for aneurysm treatment","ALL","18 Years",{"count":184,"type":185},200,"ESTIMATED","12 Months","OBSERVATIONAL","To evaluate safety and performance of the phenox GmbH Flow Diverter p64, p64 MW, and p48MW in France, this registry will include subjects with intracranial aneurysms (anterior and posterior) who are treated with a phenox GmbH Flow Diverter. The subjects will be treated according to the standard of care in the participating sites.",[190],"Intracranial Aneurysms",[192,193,194,195,196,197],"Vascular Diseases","Intracranial Arterial Diseases","Cerebrovascular Disorders","Brain Diseases","Intracranial Aneurysm","Aneurysm","2026-08-04",{"date":200,"type":201},"2026-08-05","ACTUAL",{"date":203,"type":201},"2025-03-07",{"date":205,"type":185},"2028-12",{"name":5,"class":6},11]